The method of treatment of the primary facial nerve neuropathies

 

(57) Abstract:

The invention relates to medicine, and neurology. Carry out the introduction of hydrocortisone succinate, cyanocobalamin in biologically active points. After that point is influenced by direct electric current is introduced through the needle. The current strength of 25 to 50 μa, the voltage of 60 C. the method improves the efficiency of the treatment.

The invention relates to medicine, namely to neurology and reflexology. Widely known for the prevalence of primary neuropathy of the facial nerve (PLN) among all lesions of the peripheral nervous system - up to 2-3% in different countries. Despite significant progress in the development of theoretical and practical aspects of the problem, prevalence PMLN is not reduced, and 15-32% of patients developing posterities contracture of the facial muscles or relapse of the disease.

There is a method of treatment PMLN with the use of acupuncture, electroacupuncture (I. H. Samosyuk, B. N., Lysenok Acupuncture. Kiev, Moscow, AST - Press, pp. 449-451), consisting in the application of points in the electroacupuncture - E2, E4, E6, Gi20, G18, T117, VB1, VB14, VB20, acupuncture, these biologically active points (BAP) and, in addition, E7, Gi19, IG19, VB2, TR21, TR23, VC24 on paravirt BAHT and justify the sequence of their use, lack of effectiveness, appearance posterities contracture of the facial muscles.

Closest to the claimed method is reflexotherapy (RF patent N 2106855 from 27.09.93,, M CL A 61 H 39/04, publ. BI N 8, 98, 20.03.98. "How reflexology and device for its implementation"), which consists in treatment by exposure to electro-acupuncture acupuncture point and drug introduced in the same acupuncture point, the optimal dose.

The disadvantage of this method is that in the selection of acupuncture points do not count their energy characteristics, there are no criteria for the selection of a drug and its dose and time effects of electro-acupuncture on the BAT.

The objective of the invention is the creation of a more effective method of treatment PMLN in the acute period with the most rapid clinical improvement.

This object is achieved in that pharmacopuncture is carried out by injecting 0.2 - 0.4 ml, hydrocortisone succinate in point TR17 and E7 with the subsequent needles in the same neutral point method and bringing to them a constant electric current of the power 25 to 50 μa and a voltage of 60 V, while the about during 5, 6, 8 and 12 sessions are pharmacopuncture by injection of cyanocobalamin at a dose of 100 μg in each point E7, VB1, TR23, E1 and Gi20, then in the same point set needle and connect them to the same constant current source so that the needle point E7 is the cathode and anode used needles in points VB1, TR23, E1, Gi20 alternately; at 7, 9, 10 and 11 sessions the pharmacopuncture spend points E6, E2, E4, Gi19, PC19 also cyanocobalamin in the same doses, the needle set in the same point with the connection to the DC source, and the needle at the point E6 is a cathode, and needles in the points E3, E4, Gi19, PC19 by alternately activate serve as the anode.

The novelty of the method:

1) Using pharmacopsychiatry in the specified sequence and combination leads to more rapid clinical improvement and describes a comprehensive approach, coming from the initial impact on the concentration levels of top - down (Shao Yang and Yang-min), the irritation of which more intensely perceived by the body as they are the points of regulation of the third level of energy imbalance, and, moreover, correspond to the affected muscles. The impact on the local point contributes to the restoration of neuro-mysery in the acute stage PLN during the first 4 sessions provides movement and accumulation of cations hydrocortisone in point TR17, what is achieved by removing the compression of the facial nerve in the distal segment of the canal of the facial nerve.

3) the Subsequent conduct of pharmacopsychiatry with cyanocobalamin for 8 sessions increases the activity of BAT in the affected area and leads to the recovery of neuromuscular conduction and function of facial muscles.

4) Day treatment provides rapid regression of clinical symptoms. As a result, total reflex influence on BAT positive effect of this method is extended by more than 8 days.

The proposed method is as follows: when entering a patient with complaints of pain in the ear region, swelling of side of face, dysfunction of the facial muscles, facial asymmetry, in the first three days of the disease are dehydration therapy to reduce swelling. Then assign pharmacologyfunction, which is as follows: from the fourth day of the disease to do this, use the following biologically active points (BAP): TR17 corresponding to the place of exit of the facial nerve from the bone canal of the facial nerve and E7, anatomically corresponding projection of the parotid plexus of the facial nerve.After the acute stage of the disease, which lasts about a week, the eighth day of the disease, i.e., fifth session, conducted pharmacopuncture in the Yang-min).

For pharmacopuncture used cyanocobalamin (vitamin B 12) due to its high biological activity, participation in the synthesis of nucleic acids, improve metabolism in muscle and peripheral nervous tissues. Used a total dose of 500 mcg (srednestatisticheskaya daily dose) for one session. During one session pharmacopuncture was conducted in five BAHT, 100 micrograms in every. Neutral method are needles in these points. The clip, which is the cathode, is connected to the needle at the point E7, and the clip, which is the anode, to the needles in these points in turn. This takes into account that cyanocobalamin is injected from the cathode. For irritation was used electric current of the same parameters, the exposure time of 2 min for each BAT.

These points (VB1, TR23, E1, Gi20) as a result of stimulation 24 hours. At the sixth session took the same points, they work 48 hours. At the seventh session pharmacopuncture was conducted in terms of local values: E6, E2, Gi19, PC19. The needles were placed at all points, then the clip, which is the cathode was connected to the needle at the point E6. and the clip, which is the anode, turn to the needles at the points E2, E4, Gi19, PC19, by the same parameters and duration. On the eighth day in point VB1, TR23, E1, and the force and 25 - 50 μa, the voltage 60 In such a way that the needle at the point E7 was the cathode, and the needle points VB1, TR23, E1, Gi20 turn was the anode. Procedure duration is 2 minutes Points work 96 hours.

On the ninth, tenth, eleventh session pharmacopuncture vitamin B12 carried out at points E6, E2, E4, Gi19, PC19 100 micrograms, at each point, then put the needle in the above point and was carried out by electro-puncture, and needle point E6 served as a cathode, and needles in the points E2, E4, Gi19, PC19 served alternately as anode. At last, the twelfth session after injection of cyanocobalamin in point VB1, TR23, E1, Gi20, E7 and installing them in needles were electroacupuncture according to the same scheme, the needle at the point E7 was the cathode, and the needle points VB1, TR23, E1, Gi20 were alternately anode. Points are 192 hours. The course of treatment was 12 days.

Example. Patient N. 42. He complained of pain in the right side of the face, behind the ear, the diction, the swelling of the right half of the face, biting right cheek while chewing. Ill acutely after exposure to cold the night before. Turned in the first day of the disease.

Objectively. Somatically healthy. Right eye behind in the act of blinking. Tearing of the right eye. The right corner of her mouth drooping. Lips in Lovina person. Pain when pressing on the right mastoid. Taste no violations. On radiographs of the temporal bones by Stenvers - destructive changes. Data EMG neural lesion level, elements of denervation in m. orbicularis oris dextra, I senior Jack Russell.

Diagnosis: Primary neuropathy of the facial nerve on the right, the level of the lesion distal to the chorda tympani, acute regimiento for, III senior clinical manifestations.

Were treated during the first three days of dehydration therapy, from the fourth day of the disease in terms of TR17, E7 was conducted pharmacopuncture 0.3 ml hydrocortisone succinate, then followed electroacupuncture DC power of 30 μa and a voltage of 60 V, a duration of 2 minutes

At the fourth session pain significantly decreased.

On the fifth, sixth, eighth and twelfth sessions were conducted pharmacopuncture vitamin B12 100 mcg in point: VB1, TR23, E1, Gi20, E7. This was followed by electroacupuncture according to the same parameters.

On the seventh, ninth, tenth and eleventh sessions cyanocobalamin dose of 100 μg was administered in point: E2, E4, Gi19, PC10, E6, then were electroacupuncture.

At the seventh session of pain syndr the supply of facial muscles on the right. Restored the sensitivity on the right side of the face.

The result of treatment after 20 days from the beginning was assessed as clinical recovery: recovered fully the function of facial muscles on the right, the movement in the face symmetrical.

In follow-up one year later: the full restoration of function of the facial muscles on the right, cosmetic defect associated with the transferred disease, no.

The proposed method of treatment is effective for the treatment of patients with PMLN in the acute period, contributes to a more rapid restoration of function of the facial muscles. In this way treated more than 20 patients with clear results improve.

A method of treating primary neuropathies of the facial nerve by pharmaco - and electro-acupuncture effects on biologically active points, characterized in that the pharmacopuncture is carried out by injecting 0.2 - 0.4 mm hydrocortisone succinate in point TR17 and E7 with the subsequent needles in the same neutral point method and bringing to them a constant electric current of the power 25 to 50 μa and a voltage of 60 V, and the needle at the point E7 is the cathode, and the needle at the point TR17 anode, and the treatment is 4 session 2 min each, then in the time TR23, E1 and G120, then in the same point set needle and connect them to the same constant current source so that the needle point E7 serves as a cathode and as an anode used needles in points VB1, TR23, E1, GI20 alternately, during 7, 9, 10 and 11 of the sessions pharmacopuncture cyanocobalamin spend points E6, E2, E4, C119, PC19 in the above-mentioned doses, the angles are set in the same point with the connection to the DC source and the needle at the point E6 is a cathode, and the needle points E2, E4, C1 19, PC19 by alternately activate serves as the anode.

 

Same patents:

The invention relates to medicine, therapy
The invention relates to medicine, physical therapy

The invention relates to medicine, namely to surgical dentistry

The invention relates to medicine, namely to methods for treating bronchial asthma
The invention relates to medicine, namely to the pathology, and can be used for treatment of vibration disease (WB), especially from the effects of local vibration

The invention relates to the field of agriculture, division of animal health, and in particular to methods and devices for electrical stimulation of the muscles of the abdomen and uterus in animals with pathological childbirth (weak contractions and attempts, retention of placenta)
The invention relates to medicine, namely to Pediatrics, and can be used in the treatment of chronic gastroduodenitis in children

The invention relates to medicine, namely to dermatology, and can be used in the treatment of allergic
The invention relates to medicine, namely to therapy, and can be used in the treatment of various diseases by electric shocks on biologically active points

The invention relates to medicine, namely to reflexology and can be used to maintain the health of drivers

The invention relates to agriculture, division of animal health, and in particular to methods and devices for electrical stimulation of the muscles of the uterus and disease in the postpartum period (subinvolution of the genital organs, atony and hypotonia of the uterus, endometritis)

The invention relates to medicine, namely to "gastroenterology", and for the treatment of patients with peptic ulcer of the duodenum physical factors

The invention relates to medicine, gynecology

The invention relates to medicine, obstetrics, gynecology

The invention relates to physiotherapy and reflexology, namely stimulants biologically active points of a man
The invention relates to medicine and can be used to transfer bioenergy information to the media, for example, in the manufacture of testing tools etiological diagnosis, bioactive pharmacological drugs and medical items

The invention relates to medicine, reflexology

The invention relates to medicine, namely to reflexology, and can be used for simultaneous heat and acupressure effects

The invention relates to medicine, namely to reflexology, and can be used for simultaneous heat and acupressure effects

FIELD: medicine.

SUBSTANCE: method involves administering diet with high content of nutrient fibers and restricted amount of ordinary hydrocarbons, animal fats and meat broth. Massage is done with manual massage machine Acupress being four-roller bronze or ebonite massage instrument operating along small intestine during 5-6min and then with movements across the abdomen from left to right during 3-4 min. The like movements are done with two-roller bronze or ebonite massage instrument operating along large intestine meridian symmetrically relative to the right and left arm during 4-5 min. All massage movements are done slowly. Procedures are given daily in the morning on empty stomach, before dinner and before going to bed.

EFFECT: enhanced effectiveness in treating chronic constipation cases.

4 dwg

Up!